Good and bad sides of TGFβ-signaling in myocardial infarction

Frontiers in Physiology

Volumn 6, Issue MAR, 2015, Pages 06-

  Euler, Gerhild ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Apoptosis; Fibrosis; Hypertrophy; MicroRNA; Myocardial infarction; SMAD; TAK1; Transforming growth factor beta

Indexed keywords

SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

APOPTOSIS; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

EID: 84926475525     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00006     Document Type: Review

References (49)

1. Akman, H. O., Zhang, H., Siddiqui, M. A., Solomon, W., Smith, E. L., and Batuman, O. A. (2001). Response to hypoxia involves transforming growth factor-beta2 and Smad proteins in human endothelial cells. Blood 98, 3324-3331. doi: 10.1182/blood.V98.12.3324
2. Anderton, M. J., Mellor, H. R., Bell, A., Sadler, C., Pass, M., Powell, S., et al. (2011). Induction of heart valve lesions by small-molecule ALK5 inhibitors. Toxicol. Pathol. 39, 916-924. doi: 10.1177/0192623311416259
3. Baxter, G. F., Mocanu, M. M., Brar, B. K., Latchman, D. S., and Yellon, D. M. (2001). Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK. J. Cardiovasc. Pharmacol. 38, 930-939. doi: 10.1097/00005344-200112000-00015
4. Blahna, M. T., and Hata, A. (2012). Smad-mediated regulation of microRNA biosynthesis. FEBS Lett. 586, 1906-1912. doi: 10.1016/j.febslet.2012.01.041
5. Bujak, M., Ren, G., Kweon, H. J., Dobaczewski, M., Reddy, A., Taffet, G., et al. (2007). Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation, 116(19), 2127-2138. doi: 10.1161/CIRCULATIONAHA.107.704197
6. Chen, Z., Chua, C. C., Ho, Y. S., Hamdy, R. C., and Chua, B. H. (2001). Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am. J. Physiol. Heart Circ. Physiol. 280, H2313-H2320.
7. Chua, C. C., Gao, J., Ho, Y. S., Xiong, Y., Xu, X., Chen, Z., et al. (2007). Overexpression of IAP-2 attenuates apoptosis and protects against myocardial ischemia/reperfusion injury in transgenic mice. Biochim. Biophys. Acta 1773, 577-583. doi: 10.1016/j.bbamcr.2007.01.007
8. Dandapat, A., Hu, C. P., Li, D., Liu, Y., Chen, H., Hermonat, P. L., et al. (2008). Overexpression of TGFbeta1 by adeno-associated virus type-2 vector protects myocardium from ischemia-reperfusion injury. Gene Ther. 15, 415-423. doi: 10.1038/sj.gt.3303071
9. Dobaczewski, M., Bujak, M., Li, N., Gonzalez-Quesada, C., Mendoza, L. H., Wang, X. F., et al. (2010). Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ. Res. 107, 418-428. doi: 10.1161/CIRCRESAHA.109.216101
10. Dobaczewski, M., Chen, W., and Frangogiannis, N. G. (2011). Transforming growth factor (TGF)-ß signaling in cardiac remodeling. J. Mol. Cell. Cardiol. 51, 600-606. doi: 10.1016/j.yjmcc.2010.10.033
11. Ebelt, H., Hillebrand, I., Arlt, S., Zhang, Y., Kostin, S., Neuhaus, H., et al. (2013). Treatment with bone morphogenetic protein 2 limits infarct size after myocardial infarction in mice. Shock 39, 353-360. doi: 10.1097/SHK.0b013e318289728a
12. Edgley, A. J., Krum, H., and Kelly, D. J. (2012). Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-ß. Cardiovasc. Ther. 30, e30-e40. doi: 10.1111/j.1755-5922.2010.00228.x
13. Engebretsen, K. V., Skårdal, K., Bjørnstad, S., Marstein, H. S., Skrbic, B., Sjaastad, I., et al. (2014). Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5. J. Mol. Cell. Cardiol. 76C, 148-157. doi: 10.1016/j.yjmcc.2014.08.008
14. Euler-Taimor, G., and Heger, J. (2006). The complex pattern of SMAD signaling in the cardiovascular system. Cardiovasc. Res. 69, 15-25. doi: 10.1016/j.cardiores.2005.07.007
15. Frantz, S., Hu, K., Adamek, A., Wolf, J., Sallam, A., Maier, S. K., et al. (2008). Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction. Basic. Res. Cardiol. 103, 485-492. doi: 10.1007/s00395-008-0739-7
16. Goumans, M. J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P., and ten Dijke, P. (2002). Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 21, 1743-1753. doi: 10.1093/emboj/21.7.1743
17. Guo, C., Deng, Y., Liu, J., and Qian, L. (2014). Cardiomyocyte-specific role of miR-24 in promoting cell survival. J. Cell. Mol. Med. 19, 103-112. doi: 10.1111/jcmm.12393
18. Hao, J., Ju, H., Zhao, S., Junaid, A., Scammell-La Fleur, T., and Dixon, I. M. (1999). Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J. Mol. Cell. Cardiol. 31, 667-678. doi: 10.1006/jmcc.1998.0902
19. Ha Thi, H. T., Lim, H. S., Kim, J., Kim, Y. M., Kim, H. Y., and Hong, S. (2013). Transcriptional and post-translational regulation of Bim is essential for TGF-ß and TNF-a-induced apoptosis of gastric cancer cell. Biochim. Biophys. Acta 1830, 3584-3592. doi: 10.1016/j.bbagen.2013.03.006
20. Hausenloy, D. J., and Yellon, D. M. (2004). New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc. Res. 61, 448-460. doi: 10.1016/j.cardiores.2003.09.024
21. Heger, J., Warga, B., Abdallah, Y., Meyering, B., Schlüter, K. D., and Euler, G. (2011). TGFβ receptor activation enhances cardiac apoptosis via SMAD activation and concomitant NO release. J. Cell. Physiol. 226, 2683-2690. doi: 10.1002/jcp.22619
22. Heldin, C. H., Miyazono, K., and ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471. doi: 10.1038/37284
23. Hochhauser, E., Kivity, S., Offen, D., Maulik, N., Otani, H., Barhum, Y., et al. (2003). Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am. J. Physiol. Heart Circ. Physiol., 284, H2351-H2359. doi: 10.1152/ajpheart.00783.2002
24. Huntgeburth, M., Tiemann, K., Shahverdyan, R., Schlüter, K. D., Schreckenberg, R., Gross, M. L., et al. (2011). Transforming growth factor ß1 oppositely regulates the hypertrophic and contractile response to ß-adrenergic stimulation in the heart. PLoS ONE 6:e26628. doi: 10.1371/journal.pone.0026628
25. Ikeuchi, M., Tsutsui, H., Shiomi, T., Matsusaka, H., Matsushima, S., Wen, J., et al. (2004). Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc. Res. 64, 526-535. doi: 10.1016/j.cardiores.2004.07.017
26. Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., et al. (2002). SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65-74. doi: 10.1124/mol.62.1.65
27. Kumarswamy, R., Volkmann, I., Jazbutyte, V., Dangwal, S., Park, D. H., and Thum, T. (2012). Transforming growth factor-ß-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21. Arterioscler. Thromb. Vasc. Biol. 32, 361-369. doi: 10.1161/ATVBAHA.111.234286
28. Lee, P., Sata, M., Lefer, D. J., Factor, S. M., Walsh, K., and Kitsis, R. N. (2003). Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am. J. Physiol. Heart Circ. Physiol. 284, H456-H463. doi: 10.1152/ajpheart.00777.2002
29. Lefer, A. M., Ma, X. L., Weyrich, A. S., and Scalia, R. (1993). Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proc. Natl. Acad. Sci. U.S.A. 90, 1018-1022. doi: 10.1073/pnas.90.3.1018
30. Li, Q., Xu, Y., Li, X., Guo, Y., and Liu, G. (2012). Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-ß 1-TAK1. Toxicol. Lett. 211, 91-97. doi: 10.1016/j.toxlet.2012.03.006
31. Li, T. S., Hayashi, M., Ito, H., Furutani, A., Murata, T., Matsuzaki, M., et al. (2005). Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation 111, 2438-2445. doi: 10.1161/01.CIR.0000167553.49133.81
32. Liang, H., Zhang, C., Ban, T., Liu, Y., Mei, L., Piao, X., et al. (2012). A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis. Int. J. Biochem. Cell. Biol. 44, 2152-2160. doi: 10.1016/j.biocel.2012.08.019
33. Marber, M. S., Rose, B., and Wang, Y. (2011). The p38 mitogen-activated protein kinase pathway-a potential target for intervention in infarction, hypertrophy, and heart failure. J. Mol. Cell. Cardiol. 51, 485-490. doi: 10.1016/j.yjmcc.2010.10.021
34. Matsumoto-Ida, M., Takimoto, Y., Aoyama, T., Akao, M., Takeda, T., and Kita, T. (2006). Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats. Am. J. Physiol. Heart Circ. Physiol. 290, H709-H715. doi: 10.1152/ajpheart.00186.2005
35. Okada, H., Takemura, G., Kosai, K., Li, Y., Takahashi, T., Esaki, M., et al. (2005). Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation 111, 2430-2437. doi: 10.1161/01.CIR.0000165066.71481.8E
36. Schlüter, K. D., Zhou, X. J., and Piper, H. M. (1995). Induction of hypertrophic responsiveness to isoproterenol by TGF-beta in adult rat cardiomyocytes. Am. J. Physiol. 269(Pt 1), C1311-C1316.
37. Schneiders, D., Heger, J., Best, P., Piper, H. M., and Taimor, G. (2005). SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes. Cardiovasc. Res. 67, 87-96. doi: 10.1016/j.cardiores.2005.02.021
38. Spender, L. C., Carter, M. J., O'Brien, D. I., Clark, L. J., Yu, J., Michalak, E. M., et al. (2013). Transforming growth factor-ß directly induces p53-up-regulated modulator of apoptosis (PUMA) during the rapid induction of apoptosis in myc-driven B-cell lymphomas. J. Biol. Chem. 288, 5198-5209. doi: 10.1074/jbc.M112.410274
39. Talasaz, A. H., Khalili, H., Jenab, Y., Salarifar, M., Broumand, M. A., Darabi, F., et al. (2013). N-Acetylcysteine effects on transforming growth factor-ß and tumor necrosis factor-a serum levels as pro-fibrotic and inflammatory biomarkers in patients following ST-segment elevation myocardial infarction. Drugs R D 13, 199-205. doi: 10.1007/s40268-013-0025-5
40. Tan, S. M., Zhang, Y., Connelly, K. A., Gilbert, R. E., and Kelly, D. J. (2010). Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 298, H1415-H1425. doi: 10.1152/ajpheart.01048.2009
41. van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., et al. (2008). Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. U.S.A. 105, 13027-13032. doi: 10.1073/pnas.0805038105
42. Vilahur, G., Juan-Babot, O., Peña, E., Oñate, B., Casaní, L., and Badimon, L. (2011). Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. J. Mol. Cell. Cardiol. 50, 522-533. doi: 10.1016/j.yjmcc.2010.12.021
43. Wang, J., Huang, W., Xu, R., Nie, Y., Cao, X., Meng, J., et al. (2012). MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J. Cell. Mol. Med. 16, 2150-2160. doi: 10.1111/j.1582-4934.2012.01523.x
44. Wang, Q., Feng, J., Wang, J., Zhang, X., Zhang, D., Zhu, T., et al. (2013). Disruption of TAB1/p38a interaction using a cell-permeable peptide limits myocardial ischemia/reperfusion injury. Mol. Ther. 21, 1668-1677. doi: 10.1038/mt.2013.90
45. Wharton, K., and Derynck, R. (2009). TGFbeta family signaling: novel insights in development and disease. Development 136, 3691-3697. doi: 10.1242/dev.040584
46. Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., et al. (2007). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952-961. doi: 10.1038/nm1613
47. Zeisberg, M., Hanai, J., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., et al. (2003). BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9, 964-968. doi: 10.1038/nm888
48. Zhang, B., Zhou, M., Li, C., Zhou, J., Li, H., Zhu, D., et al. (2014). MicroRNA-92a inhibition attenuates hypoxia/reoxygenation-induced myocardiocyte apoptosis by targeting Smad7. PLoS ONE 9:e100298. doi: 10.1371/journal.pone.0100298
49. Zhang, D., Gaussin, V., Taffet, G. E., Belaguli, N. S., Yamada, M., Schwartz, R. J., et al. (2000). TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat. Med. 6, 556-563. doi: 10.1038/75037